ATOSSA THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $27.2M | $39.6M |
| FY2021 | — | $138.1M | $136.4M |
| FY2022 | — | $118.0M | $110.9M |
| FY2023 | — | $91.0M | $88.5M |
| FY2024 | — | $71.5M | $71.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $27.2M | $39.6M |
| FY2021 | — | $138.1M | $136.4M |
| FY2022 | — | $118.0M | $110.9M |
| FY2023 | — | $91.0M | $88.5M |
| FY2024 | — | $71.5M | $71.1M |